| scholarly article | Q13442814 |
| P50 | author | Abhinav Kanwal | Q60890961 |
| Riyue Bao | Q86979525 | ||
| P2093 | author name string | Mahesh P Gupta | |
| Sadhana A Samant | |||
| Vinodkumar B Pillai | |||
| P2860 | cites work | SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress | Q24313709 |
| SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span | Q24315083 | ||
| Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy | Q24555065 | ||
| Regulation of myostatin activity and muscle growth | Q24555817 | ||
| Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting | Q24609841 | ||
| SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells | Q24626021 | ||
| Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure | Q24646933 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member | Q28237287 | ||
| The sirtuin SIRT6 regulates lifespan in male mice | Q28260687 | ||
| Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB | Q28389686 | ||
| Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase | Q28505800 | ||
| Genomic instability and aging-like phenotype in the absence of mammalian SIRT6 | Q28509079 | ||
| Identification of ubiquitin ligases required for skeletal muscle atrophy | Q28582211 | ||
| The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha | Q28588941 | ||
| Mammalian sirtuins: biological insights and disease relevance | Q29614496 | ||
| Recent progress in the biology and physiology of sirtuins | Q29617573 | ||
| Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity | Q33419373 | ||
| SIRT6 Overexpression Improves Various Aspects of Mouse Healthspan. | Q51574303 | ||
| Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. | Q51805331 | ||
| Insulin-like growth factor-1 suppresses the Myostatin signaling pathway during myogenic differentiation. | Q53436647 | ||
| Myostatin, a transforming growth factor-? superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct | Q56874784 | ||
| Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo | Q73596145 | ||
| Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells | Q80775366 | ||
| Resistance to body fat gain in 'double-muscled' mice fed a high-fat diet | Q82226677 | ||
| SIRT6 regulates osteogenic differentiation of rat bone marrow mesenchymal stem cells partially via suppressing the nuclear factor-κB signaling pathway | Q87259676 | ||
| Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome | Q38105829 | ||
| Myostatin/activin pathway antagonism: molecular basis and therapeutic potential | Q38110659 | ||
| Transcriptional effects of chronic Akt activation in the heart. | Q38290130 | ||
| Muscle wasting in disease: molecular mechanisms and promising therapies | Q38303979 | ||
| The complex role of SIRT6 in carcinogenesis | Q38683187 | ||
| Myostatin Neutralization Results in Preservation of Muscle Mass and Strength in Preclinical Models of Tumor-Induced Muscle Wasting | Q38882868 | ||
| Elevated expression of activins promotes muscle wasting and cachexia. | Q39038278 | ||
| Myostatin induces p300 degradation to silence cyclin D1 expression through the PI3K/PTEN/Akt pathway | Q39983306 | ||
| Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors | Q40248450 | ||
| Cancer cachexia is regulated by selective targeting of skeletal muscle gene products | Q40529830 | ||
| NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes | Q40852716 | ||
| Angiotensin II Induces Skeletal Muscle Atrophy by Activating TFEB-Mediated MuRF1 Expression | Q41807919 | ||
| Aberrant repair and fibrosis development in skeletal muscle | Q41822988 | ||
| Sirtuins at a glance. | Q42650245 | ||
| SIRT6 protects against pathological damage caused by diet-induced obesity | Q43202807 | ||
| Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice | Q43227383 | ||
| Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro | Q44226350 | ||
| Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin | Q44489665 | ||
| A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers | Q45776651 | ||
| Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle | Q46359311 | ||
| Myostatin is a human placental product that regulates glucose uptake | Q46933201 | ||
| Myostatin activation in patients with advanced heart failure and after mechanical unloading. | Q33803837 | ||
| Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct | Q33864336 | ||
| Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review | Q33956866 | ||
| Cachexia: a new definition | Q34013455 | ||
| The nuclear factor NF-kappaB pathway in inflammation | Q34114512 | ||
| Cachexia as a major underestimated and unmet medical need: facts and numbers | Q34176827 | ||
| Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study | Q34187927 | ||
| Myostatin decreases with aerobic exercise and associates with insulin resistance | Q34286092 | ||
| SIRT6 Deficiency Results in Severe Hypoglycemia by Enhancing Both Basal and Insulin-stimulated Glucose Uptake in Mice | Q34299195 | ||
| Actin dynamics is rapidly regulated by the PTEN and PIP2 signaling pathways leading to myocyte hypertrophy | Q34627816 | ||
| Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. | Q34629952 | ||
| Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway | Q34765114 | ||
| Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease | Q34813421 | ||
| The role of myostatin in muscle wasting: an overview | Q35223987 | ||
| The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun | Q35458082 | ||
| Regulation of muscle mass by myostatin | Q35912777 | ||
| Enhanced insulin sensitivity in skeletal muscle and liver by physiological overexpression of SIRT6 | Q36246143 | ||
| Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells | Q36364263 | ||
| Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice | Q36451932 | ||
| Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects | Q36515547 | ||
| SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2. | Q36559986 | ||
| Myostatin directly regulates skeletal muscle fibrosis | Q36744190 | ||
| Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. | Q37023094 | ||
| NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases | Q37075935 | ||
| Myostatin (GDF-8) as a key factor linking muscle mass and bone structure | Q37121916 | ||
| Autophagy is induced in the skeletal muscle of cachectic cancer patients | Q37128604 | ||
| Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention | Q37293352 | ||
| Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism | Q37318200 | ||
| Nuclear positioning in muscle development and disease | Q37385211 | ||
| Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt. | Q37421047 | ||
| NF-kappaB signaling: a tale of two pathways in skeletal myogenesis | Q37731207 | ||
| Signaling pathways perturbing muscle mass | Q37732100 | ||
| Understanding the mechanisms and treatment options in cancer cachexia | Q38064733 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 11877 | |
| P577 | publication date | 2017-09-19 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy | |
| P478 | volume | 7 |
| Q92845238 | A high-fat diet reverses metabolic disorders and premature aging by modulating insulin and IGF1 signaling in SIRT6 knockout mice |
| Q90295069 | Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy |
| Q64097167 | Myostatin gene promoter: structure, conservation and importance as a target for muscle modulation |
| Q59791878 | SIRT6 Is Involved in the Progression of Ovarian Carcinomas via β-Catenin-Mediated Epithelial to Mesenchymal Transition |
| Q51760982 | Sirtuins as Mediator of the Anti-Ageing Effects of Calorie Restriction in Skeletal and Cardiac Muscle. |
Search more.